Recent Security Class Actions

Alexion Pharmaceuticals Inc. Common Stock (NASDAQ: ALXN)

Company Name:Alexion Pharmaceuticals Inc. Common Stock
Stock Symbol:NASDAQ: ALXN
Class Period Start:01/30/2014
Class Period End (inclusive):05/26/2017
Filing Deadline:01/16/2017

According to the law firm press release, Alexion, a biopharmaceutical company, develops and commercializes therapeutic products. Among the Company’s products is Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder, and atypical hemolytic uremic syndrome (aHUS), a genetic disease.